ASHI Webinar August 2026

Course overview

Hour 1 *Describe the physiologic role of endogenous GLP-1 and GIP in glucose regulation, appetite control, and energy balance. *Explain the mechanism of action of GLP-based medications at the pancreatic, GI, and CNS levels. *Differentiate short-acting and long-acting GLP-based medications on pharmacokinetics, dosing, and clinical effects. *Identify FDA-approved GLP-based medications and their approved indications. *Recognize emerging multi-system effects that may influence musculoskeletal health and rehabilitation outcomes. Hour 2 *Summarize the clinical benefits of GLP-based medications for weight loss and cardiometabolic risk reduction. *Identify common, uncommon, and serious adverse effects associated with GLP-based therapy. *Explain implications of GLP/GIP-associated lean mass and bone density loss for musculoskeletal health. *Recognize red flags requiring referral or co-management with medical providers. *Integrate appropriate counseling, exercise recommendations, and interprofessional referral strategies. Hour 3 - Muscle Physiology *Muscle and activity. *Normal dietary intake. *Restricted dietary intake. *Influence of GLP-1 and weight loss drugs. *Physical exam findings. Hour 4 - Sarcopenia *Definition and Impact. *Physical exam findings. *Exercise principles. *Intervention optimization. *Pros and cons.